Voltage-gated calcium channel (parasite) (VGCC (parasite))

Voltage-gated calcium channels in parasites are integral membrane proteins that mediate calcium influx in response to changes in membrane potential, facilitating essential calcium-dependent processes including muscle contraction, neurotransmission, and secretion in various parasitic species such as schistosomes, nematodes, trypanosomes, and leishmania[1][2][3][7]. These channels are multimeric, typically comprising a pore-forming α1 subunit and auxiliary subunits (notably a variant β subunit in some parasites), which may confer unique pharmacological sensitivities absent in mammalian channels[1][7][3]. Parasite VGCCs are validated therapeutic targets, as they are critical for parasite survival, motility, and reproduction, and are targeted by drugs such as praziquantel and various calcium channel blockers, either disrupting calcium homeostasis directly or altering vital neuromuscular processes, leading to paralysis and/or death of the parasite[1][2][6][7]. Unique structural features of parasite VGCCs, such as platyhelminth-specific β subunits, offer opportunities for selective drug design with fewer host side effects, though challenges remain regarding cross-reactivity, therapeutic index, and the development of resistance[1][4][6][7].

Other names

Voltage-dependent calcium channel (parasite)VOCC (parasite)CaV channel (parasite)

Calcium channel blockade (inhibition of Ca²⁺ entry) Disruption of Ca²⁺ homeostasis Induction of sustained muscle contraction and disruption of parasite tegument (praziquantel) Inhibition of parasite locomotion and reproduction